Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Hologic, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Hologic, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Hologic, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Hologic, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Hologic, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 3 |
| Hologic, Inc., Medical Equipment, Deal Details | 13 | 37 |
| Asset Purchase | 13 | 1 |
| Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million | 13 | 2 |
| Venture Financing | 15 | 1 |
| Roka Bioscience Secures US$20 Million In Series C Financing | 15 | 2 |
| Pacific Biosciences Secures Additional US$59 Million In Series F Round Of Financing | 17 | 2 |
| Private Equity | 19 | 1 |
| Percipient Capital Completes Management Buyout Of Elucigene Diagnostics | 19 | 1 |
| Partnerships | 20 | 1 |
| MeVis Medical Enters into Licensing Agreement with Hologic | 20 | 1 |
| Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker | 21 | 1 |
| Microsulis Medical Enters Into Licensing Agreement With Hologic | 22 | 1 |
| IsoRay Enters Into Exclusive Licensing Agreement With Hologic | 23 | 1 |
| Ethicon Endo-Surgery Enters Into Cross-Licensing Agreement With Hologic | 24 | 1 |
| U.S. Department of Health and Human Services Enters into Agreement with Hologic | 25 | 1 |
| Bovie Medical Enters into Agreement with Hologic | 26 | 1 |
| Metamark Genetics Enters into Distribution Agreement with Hologic | 27 | 1 |
| Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic | 28 | 1 |
| Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight | 29 | 1 |
| Quest Diagnostics Enters Into Co-Development Agreement With Hologic | 30 | 2 |
| Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies | 32 | 1 |
| Transasia Enters Into Distribution Agreement With Gen-Probe | 33 | 1 |
| Hologic Enters Into Co-Marketing Agreement With SuperSonic Imagine | 34 | 1 |
| Life Technologies Enters Into An Agreement With Gen-Probe | 35 | 1 |
| Debt Offering | 36 | 1 |
| Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 | 36 | 1 |
| Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion | 37 | 1 |
| Hologic Completes Private Placement Of US$450 Million | 38 | 1 |
| Asset Transactions | 39 | 1 |
| Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million | 39 | 2 |
| Acquisition | 41 | 1 |
| Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion | 41 | 2 |
| Hologic Acquires Beijing Healthcome For Up To US$17 Million | 43 | 1 |
| Hologic Acquires TCT International | 44 | 1 |
| Hologic Acquires Interlace Medical | 45 | 2 |
| Gen-Probe Acquires GTI Diagnostics | 47 | 1 |
| Hologic Completes Acquisition Of Sentinelle Medical | 48 | 2 |
| Hologic, Inc. - Key Competitors | 50 | 1 |
| Key Employees | 51 | 1 |
| Locations And Subsidiaries | 52 | 3 |
| Head Office | 52 | 1 |
| Other Locations &Subsidiaries | 52 | 3 |
| Recent Developments | 55 | 1 |
| Strategy And Business Planning | 55 | 1 |
| Apr 08, 2015: Luxembourg National Health Laboratory Adopts Hologic s World Class Cervical Health Solutions for Screening Programme | 55 | 1 |
| Feb 23, 2015: Hologic s Tepnel Pharma Services Expands Portfolio to Include Companion Diagnostic Development | 56 | 1 |
| Financial Announcements | 57 | 1 |
| Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 | 57 | 2 |
| Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 | 59 | 1 |
| Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 | 60 | 2 |
| Nov 04, 2015: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2015 | 62 | 2 |
| Jul 29, 2015: Hologic Announces Financial Results for Third Quarter of Fiscal 2015 | 64 | 1 |
| Apr 29, 2015: Hologic Announces Financial Results for Second Quarter Fiscal 2015 | 65 | 1 |
| Jan 28, 2015: Hologic Announces Financial Results For First Quarter Fiscal 2015 | 66 | 1 |
| Jan 12, 2015: Hologic Preliminary Revenues Increased 7% to $653 Million in the First Quarter of Fiscal 2015 | 67 | 1 |
| Corporate Communications | 68 | 1 |
| Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors | 68 | 1 |
| Jun 17, 2015: Hologic Announces Changes to Board of Directors | 69 | 1 |
| Jan 20, 2015: Hologic Announces Additions to Executive Leadership Team | 70 | 1 |
| Legal and Regulatory | 71 | 1 |
| Jan 19, 2016: Hologic s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services | 71 | 1 |
| Jun 03, 2015: NICE issues final diagnostics guidance on prostate cancer tests and consults on draft guidance on tests for bacterial infection and skin cancer | 72 | 2 |
| Product News | 74 | 1 |
| Jan 06, 2016: Metamark Genetics to Serve as Exclusive Sales Agent for Hologic s Proprietary Prostate Cancer Test | 74 | 1 |
| Oct 20, 2015: Hologic Receives European Regulatory Approval for New Molecular Test to Confirm Hepatitis C Infection and Quantify Viral Load | 75 | 1 |
| Apr 16, 2015: Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology | 76 | 1 |
| Apr 01, 2015: Hologic s Aptima HPV Assay to be EBM-Reimbursed for Cervical Screening in Germany | 77 | 1 |
| Other Significant Developments | 78 | 1 |
| Jul 21, 2016: Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma | 78 | 1 |
| Dec 21, 2015: Hologic Applauds Passage of Federal Measures that Preserve Access to Mammography for Breast Cancer Screening and Increase Incentives for Biomedical Research and Development | 79 | 1 |
| Jun 10, 2015: New Approach on HIV Viral Load Testing | 80 | 1 |
| May 29, 2015: Hologic Enters into Five-Year Secured Credit Agreement | 81 | 1 |
| Appendix | 82 | 1 |
| Methodology | 82 | 1 |
| About GlobalData | 82 | 1 |
| Contact Us | 82 | 1 |
| Disclaimer | 82 | 1 |